Refine by
Mammograph Articles & Analysis
37 news found
RTI Group, a global leader in Quality Assurance (QA) of X-ray imaging, proudly announces a landmark year marked by exceptional financial performance, significant market expansion, and strategic innovations. The company exceeded its revenue target, achieving over 125 million SEK in 2024, representing a remarkable growth of more than 20 percent compared to the previous ...
We are proud to announce that the RTI Calibration Laboratory in Mölndal, Sweden, has officially achieved ISO 17025 accreditation for Half Value Layer (HVL) calibration. This milestone allows us to expand our services, offering customers accredited HVL calibration alongside our existing ISO 17025 accredited calibrations for Tube Voltage, Air Kerma, mA/mAs, Luminance, and ...
Ultravist-300, -370 receives green light for indication extension for use in contrast-enhanced mammography (CEM) in a European Workshare Procedure CEM is emerging modality combining digital mammography with the administration of a contrast agent Strategically expands Bayer’s portfolio in breast imaging, including contrast agents and injectors Bayer announced today that its ...
ByBayer AG
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in Health & Care Award. This partnership marks another significant step in the journey to build an evidence base to demonstrate the effectiveness and safety of artificial intelligence in NHS breast cancer screening. ...
QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia™ ABUS in breast screening for asymptomatic dense breasted women whose mammogram was negative. QVCAD is the next generation CAD system for automated breast ultrasound ("ABUS") based on deep learning algorithms. The QVCAD innovative C-Thru technology combined with ABUS has demonstrated a 33% improved ...
The Transpara AI breast care solution, now being used in over 30 countries worldwide to find breast cancers faster and earlier, has 'remarkable potential' to reduce Radiologists' workload, according to a leading research team in Spain. The team at the renowned University Hospital Reina Sofia in Cordoba, has launched a world first prospective 2D AND 3D study to see how they could help ...
Kheiron Medical Technologies today announced the appointment of Dr. Wendy DeMartini, Dr. Elizabeth Morris, and Dr. Amy Patel to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intelligence solutions to the US market to help radiologists detect breast cancer earlier. Kheiron is committed to assembling an inclusive advisory board ...
The team running the country's largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous contribution of this technology to breast cancer detection: not only to reduce the number of false positives but also to reduce radiologists' workload by over 60%. In Copenhagen, the biannual breast screening programme for women aged from 50 to 69, has been ...
While Artificial intelligence (AI) has shown promising results for cancer detection in mammographic screening, solid evidence based on complete follow up of participants and accurate characterization of cancers remains sparse. ...
bout two years after the outbreak of COVID-19, many resources are still being used in the fight against this new virus. Nevertheless, the number of breast cancer cases in Italy are still very high: according to the report “The numbers of cancer in Italy”, published by AIRTUM and AIOM, in 2020 about 55.000 new cases were diagnosed in Italy among women (as of today, estimates for 2021 ...
CureMetrix, Inc., a global healthcare technology company that delivers AI-driven software for radiology once again joins forces with AuntMinnie and AuntMinnieEurope, along with industry experts, for the AuntMinnie.com 2022 Virtual Conference - AI, Women’s Health, and More - to be held on March 30 and 31, 2022. Women want to know that the latest technology is supporting their healthcare ...
Following the success of the world's leading AI Breast Care system, Transpara®, now in use across the US and in 30 countries worldwide, ScreenPoint Medical, the company that developed Transpara, has appointed Mark Koeniguer as its new CEO to lead the next phase of growth and accelerate the company's international expansion. Koeniguer, who has extensive experience leading and growing ...
Seno Medical’s Imagio Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category and Diagnostics sub-category. The Edison Awards program is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation. Past winners have included Fortune 500s, small start-ups, ...
However, some women may perceive this difficulty to the point of giving up carrying out their mammographic checks regularly. Increasingly accessible screenings and mammography examinations in case of motor disability To overcome the problem, the clinic or hospital should acquire the latest generation mammography equipment with an adequate height adjustment system and an ...
Following the success of the world's leading AI Breast Care system, Transpara®, now in use across the US and in 30 countries worldwide, ScreenPoint Medical, the company that developed Transpara, is to launch a major expansion. The FDA and CE marked Transpara AI software reads mammograms to find cancers faster and at an earlier stage. 2022 will see a larger global team and further research ...
We are happy to announce that on December 15, 2021, Metaltronica SpA has received 510(k) clearance from the U.S. Food and Drug Administration for its Helianthus Full-Field Digital Mammography ...
A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s Imagio opto-acoustic ultrasound (OA/US) breast imaging provides significantly better specificity than ultrasound alone. The poster, “Performance of Optoacoustic Ultrasound with an Artificial Intelligence-based Decision Support Tool vs ...
QView Medical, a breast cancer detection pioneer and maker of the FDA-approved artificial intelligence (AI) software system for breast cancer screening, and GE Healthcare today announced that QView's QVCAD software can be launched on GE Healthcare's Invenia™ ABUS 2.0 (Automated Breast Ultrasound), which has an open platform technology that allows the integration of third-party AI tools for ...
CureMetrix, Inc., a global healthcare technology company that develops AI-based software for radiology, will present multiple in-person and virtual sessions at the 2021 Radiological Society of North American (RSNA) Scientific Assembly and Annual Meeting, a hybrid event that will take place both online and live at McCormick Place in Chicago, IL, November 28 to December 2, 2021. Notably, at the ...
IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced that a peer reviewed article titled, “VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in ...